Skip to content
Search

Latest Stories

Cimetidine, Famotidine and Nizatidine face supply disruption

Pb Staff writer
By Pb Staff writerOct 29, 2020
Pb Staff writer
See Full Bio

The H2-antagonists including Cimetidine, Famotidine, and Nizatidine are facing supply disruption. Latest update on the supply of these products is given below…

ProductSupplierCurrent Stock PositionAnticipated Resupply dateDetail
Famotidine 20mg tabletsTilomed LaboratoriesLimited suppliesEarly December 2020Unlicensed supplies have been sourced
Teva UKOut of stockMid November 2020
Famotidine 40mg tabletsTilomed LaboratoriesIn stockN/A
Teva UKLimited suppliesEnd November 2020
Cimetidine 200mg tabletsEnnogen PharmaOut of stockJune 2021Unlicensed supplies have been sourced
MedreichOut of stockto be confirmed
Cimetidine 400mg tabletsEnnogen PharmaOut of stockJune 2021
MedreichOut of stockto be confirmed
Cimetidine 800mg tabletsEnnogen PharmaOut of stockJune 2021
MedreichOut of stockto be confirmed
Cimetidine 200mg/5ml oral solutionRosemont PharmaceuticalsIn stockn/a
Nizatidine 150mg tabletsMylanOut of stockEarly January 2021Unlicensed supplies have been sourced
MedreichOut of stockto be confirmed
RelonchemOut of stockEnd November 2020
Nizatidine 300mg tabletsMylanOut of stockEarly January 2021Unlicensed supplies of Nizatidine 150mg capsules have been sourced
MedreichOut of stockto be confirmed
RelonchemOut of stockIn stock

Alium Medical,  Mawdsley’s Unlicensed, Durbin PLC, and Target Healthcare have confirmed that they can source unlicensed Cimetidine 200mg, 400mg, and 800mg tablets. The three drug manufacturers have also assured that they can supply Famotidine tablets 20mg and 40mg

Ennogen and UL Global will be able to supply Cimetidine 200mg, 400mg and famotidine 20mg and 40mg tablets respectively to avert any severe scarcity of the medicines.

Mawdsley’s Unlicensed and Target Healthcare have confirmed that they can source unlicensed Nizatidine capsules.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Cimetidine tablets cannot be issued.

If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Cimetidine (strength) tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.

Related News

Community pharmacy has a “vital role to play in rebuilding our NHS” Starmer tells Sigma Conference
News

Community pharmacy has a “vital role to play in rebuilding our NHS” Starmer tells Sigma Conference

More For You

Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online

Kenalog® can cause serious mental health problems.

gettyimages

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

Patients are being urged to avoid buying unlicensed medications such as Kenalog® online to treat hay fever symptoms this spring, as pharmacists report a sharp rise in public interest in the drug.

The National Pharmacy Association (NPA), which represents over 6000 independent community pharmacies, has warned patients that buying medication from unregulated sellers, such as beauty salons and from social media sites, could serious health risks.

Keep ReadingShow less
The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc